We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · April 20, 2017

Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome

The American Journal of Gastroenterology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The American Journal of Gastroenterology
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome
Am. J. Gastroenterol 2017 Mar 28;[EPub Ahead of Print], A Wasilewski, U Lewandowska, P Mosinska, C Watala, M Storr, J Fichna, T Venkatesan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading